SCHEMBL3372347

SCHEMBL3372347

O=C1c2ccc(Cl)cc2CCN1Cc1ccc(F)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.52
HRH3 Q9Y5N1 9/20 0.51
LMNA P02545 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
HTT P42858 2/20 0.50
ALDH1A1 P00352 2/20 0.50
ADAM17 P78536 1/20 0.47
NCOA3 Q9Y6Q9 1/20 0.47
NPC1 O15118 1/20 0.47
TDP1 Q9NUW8 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
POLB P06746 1/20 0.46
KCNH2 Q12809 1/20 0.45
AKR1B1 P15121 1/20 0.45
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
PRMT5 O14744 1/20 0.43
WDR77 Q9BQA1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25309982 0.88 LMNA (0.52) GRM5HRH3LMNASMN1; SMN2L3MBTL1
SCHEMBL29438666 0.88 LMNA (0.52) GRM5HRH3LMNASMN1; SMN2L3MBTL1
SCHEMBL7533063 0.82 GRM5 (0.67) GRM5HRH3LMNASMN1; SMN2L3MBTL1
SCHEMBL29438656 0.82 LMNA (0.60) GRM5LMNASMN1; SMN2L3MBTL1HTT
SCHEMBL25260183 0.78 LMNA (0.64) GRM5HRH3LMNASMN1; SMN2L3MBTL1
SCHEMBL27046207 0.78 LMNA (0.43) GRM5HRH3LMNASMN1; SMN2L3MBTL1
SCHEMBL16333639 0.77 LMNA (0.49) GRM5HRH3LMNASMN1; SMN2L3MBTL1
SCHEMBL8547964 0.76 HRH3 (0.49) GRM5HRH3LMNASMN1; SMN2L3MBTL1
SCHEMBL29438621 0.75 GRM5 (0.49) GRM5HRH3LMNASMN1; SMN2L3MBTL1
SCHEMBL4881755 0.75 ITGB3 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010052222-A1 (DIHYDRO)NAPHTHYRIDINONE DERIVATIVES AS HISTAMINE H3 RECEPTOR ANTAGONISTS EVOTEC NEUROSCIENCES GMBH (DE) 2010-05-14 WO disclosed